EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY 4.0

Stereotactic cardiac radiotherapy for refractory ventricular tachycardia in structural heart disease patients: a systematic review

Amulya Gupta iD, Zeeshan Sattar iD, Nourhan Chaaban, Sagar Ranka iD, Cameron Carlson, Farhad Sami iD, Clifford G Robinson iD, Phillip S Cuculich iD, Seth H Sheldon iD, Madhu Reddy, David Akhavan iD, Amit Noheria iD

Europace · 26.12.2024 · 27 (1)

DOI: 10.1093/europace/euae305 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Europace, online erschienen am 24.12.2024. Verfasst von Amulya Gupta und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Medicine, The University of Kansas Medical Center, 3901 Rainbow Blvd., Mail Stop 4023, Kansas City, KS 66160, USA. Hauptthemen laut MEDLINE: Radiosurgery, Tachycardia, Ventricular. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Among patients with structural heart disease with ventricular tachycardia (VT) refractory to medical therapy and catheter ablation, cardiac stereotactic body radiotherapy (SBRT) is a paradigm-changing treatment option. This study aims to assess the efficacy of cardiac SBRT in refractory VT by comparing the rates of VT episodes, anti-tachycardia pacing (ATP) therapies, and implantable cardioverter-defibrillator (ICD) shocks post-SBRT with pre-SBRT. Methods and results We performed a comprehensive literature search and included all clinical studies reporting outcomes on cardiac SBRT for VT. Treatment efficacy was evaluated as random-effects pooled rate-ratios of VT episodes, ATP therapies and ICD shocks post-SBRT (after 6-week blanking) and pre-SBRT, with patients serving as their own controls. Post-SBRT overall survival was assessed using Kaplan–Meier method. We included 23 studies published 2017–24 reporting on 225 patients who received cardiac SBRT, with median follow-up 5.8–28 months. There was significant heterogeneity among the studies for all three efficacy endpoints (P < 0.00001). The random-effects pooled rate-ratios of VT episodes, ATP therapies and ICD shocks post- vs. pre-SBRT were 0.10 (95% CI 0.06, 0.16), 0.09 (0.05, 0.15), and 0.09 (0.05, 0.17), respectively (all P < 0.00001). The most common reported complications included pericardial (8.0%, including 0.9% late oesophagogastro-pericardial fistula) and pulmonary (5.8%). There was no change in left ventricular ejection fraction post-SBRT (P = 0.3) but some studies reported an increase in mitral regurgitation. The combined 3-, 12-, and 24-month overall patient survival was 0.86 (0.80, 0.90), 0.72 (0.65, 0.78), and 0.57 (0.47, 0.67), respectively.

Conclusion

Among patients with refractory VT in context of structural heart disease, VT burden and ICD shocks are dramatically reduced following cardiac SBRT. The overall mortality in this population with heart failure and refractory VT receiving palliative cardiac SBRT remains high.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RadiosurgeryTachycardia, VentricularHumansDefibrillators, ImplantableTreatment OutcomeMaleElectric CountershockFemaleCardiac Pacing, Artificial

Stichwörter der Autor:innen

CardiacMeta-analysisRadioablationRadiotherapySABRSBRTSTARStereotactic ablative body radiotherapyStereotactic arrhythmia radioablationStereotactic body radiotherapyVTVentricular tachycardia

Autor:innen und Institutionen

  • Department of Cardiovascular Medicine, The University of Kansas Medical Center, 3901 Rainbow Blvd., Mail Stop 4023, Kansas City, KS 66160, USA.
  • Department of General and Hospital Medicine, The University of Kansas Medical Center, Kansas City, KS, USA.
  • Department of Internal Medicine, The University of Kansas School of Medicine, Wichita, KS, USA.
  • Division of Cardiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • University of Denver, Natural Sciences and Mathematics, Denver, CO, USA.
  • Division of Cardiology, University of Iowa, Iowa City, IA, USA.

ORCID-Profile: Amulya Gupta, Zeeshan Sattar, Sagar Ranka, Farhad Sami, Clifford G Robinson, Phillip S Cuculich, Seth H Sheldon, David Akhavan, Amit Noheria

Zitieren

APA

Gupta, A., Sattar, Z., Chaaban, N., Ranka, S., Carlson, C., Sami, F., Robinson, C. G., Cuculich, P. S., Sheldon, S. H., Reddy, M., Akhavan, D., & Noheria, A. (2024). Stereotactic cardiac radiotherapy for refractory ventricular tachycardia in structural heart disease patients: a systematic review. Europace, 27(1). https://doi.org/10.1093/europace/euae305

Vancouver

Gupta A, Sattar Z, Chaaban N, Ranka S, Carlson C, Sami F, et al. Stereotactic cardiac radiotherapy for refractory ventricular tachycardia in structural heart disease patients: a systematic review. Europace. 2024;27(1). doi:10.1093/europace/euae305

BibTeX
@article{Gupta2024,
  author = {Gupta, Amulya and Sattar, Zeeshan and Chaaban, Nourhan and Ranka, Sagar and Carlson, Cameron and Sami, Farhad and Robinson, Clifford G and Cuculich, Phillip S and Sheldon, Seth H and Reddy, Madhu and Akhavan, David and Noheria, Amit},
  title = {Stereotactic cardiac radiotherapy for refractory ventricular tachycardia in structural heart disease patients: a systematic review},
  journal = {Europace},
  year = {2024},
  volume = {27},
  number = {1},
  doi = {10.1093/europace/euae305}
}
Kostenlos starten →